| December 20, 2005 |
Forbes Medi-Tech Launches Cholesterol-Lowering Ingredient Reducol(tm) in the UK |
| December 02, 2005 |
Forbes Medi-Tech Initiates Dosing Phase in Clinical Trial for Cholesterol-Lowering Drug, FM-VP4 |
| November 14, 2005 |
Forbes Medi-Tech Announces Third Quarter 2005 Financial Results |
| November 11, 2005 |
Forbes Medi-Tech Announces Timing of Third Quarter Financial Results |
| November 03, 2005 |
Forbes Medi-Tech to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference |
| November 02, 2005 |
Forbes Medi-Tech Initiates US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4 |
| October 27, 2005 |
Forbes Medi-Tech Completes US$6 Million Private Placement |
| October 03, 2005 |
Forbes Medi-Tech Receives FDA Clearance to Initiate US Phase II Trial for Cholesterol-Lowering Drug, FM-VP4 |
| September 28, 2005 |
Phyto-Source Manufacturing Facility Remains Intact After Hurricane Rita |
| September 15, 2005 |
Forbes Medi-Tech Preclinical Study Results Demonstrate Cholesterol-Lowering Effects of FM-VP4/Statin (Zocor(r)) Combination and Effects on Obesity~ |
| September 14, 2005 |
~Forbes Medi-Tech to Present at Merriman Curhan Ford & Co. Investor Summit~ |
| August 31, 2005 |
Forbes Medi-Tech Submits IND Application for Cholesterol-Lowering Drug, FM-VP4 |
| August 23, 2005 |
Forbes Medi-Tech Makes Valuable Addition to the Board of Directors |
| August 11, 2005 |
Forbes Medi-Tech Announces 112% Increase in Second Quarter 2005 Revenue |
| June 30, 2005 |
Forbes Medi-Tech Announces FM-VP4 Study Results to be Presented at AAPS Conference |
| June 27, 2005 |
Forbes Medi-Tech Completes FM-VP4 Toxicity Study |
| May 16, 2005 |
Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2005 |
| May 02, 2005 |
Forbes Medi-Tech Announces Product Launch with Kesko of Finland |
| March 30, 2005 |
Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended December 31, 2004 |
| March 29, 2005 |
Forbes Medi-Tech Announces Timing of Year End Financial Results and AGM |
| March 02, 2005 |
Forbes Medi-Tech Receives European Approval for Reducol(tm) in Seven Major Food Groups |
| February 01, 2005 |
Forbes Medi-Tech Initiates Toxicity Study on FM-VP4 to Support US Phase II trial for Cholesterol-Lowering Drug |
| January 12, 2005 |
Forbes Medi-Tech Provides 2005 Revenue Guidance |
